INMB SCHEDULE 13G/A: SEC filing
Highbridge Capital Management LLC
Filed with the SEC on · accession 0000919574-26-007944
INMB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Highbridge Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 1,454,400 shares (4.98%) of Inmune Bio common stock, consisting of shares issuable upon exercise of warrants held by Highbridge Funds. The stock moved -8.4% by the first close after the filing.
Summary of the filing
Highbridge Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 1,454,400 shares (4.98%) of Inmune Bio common stock, consisting of shares issuable upon exercise of warrants held by Highbridge Funds. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
How INMB stock reacted
Close before
$1.05
Nov 13, 2026
First close after
-8.42%
$0.96
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INMB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INMB?
Click hereFrequently asked questions
What did INMB file with the SEC on Nov 16, 2026?
INMB filed a SCHEDULE 13G/A (SEC filing). Highbridge Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 1,454,400 shares (4.98%) of Inmune Bio common stock, consisting of shares issuable upon exercise of warrants held by Highbridge Funds. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did INMB stock react to this filing?
INMB closed at $1.05 before the filing and $0.96 on Nov 16, 2026 (-8.42%).
Other INMB SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · Secondary offeringOct 29, 2026
- 424B5 · Secondary offeringOct 29, 2026
- 8-K · Material agreementOct 21, 2026
- 8-K · Board changeSep 14, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJul 31, 2026
- 8-K · Material agreementJul 1, 2026
- 8-K · Fda approvalJun 23, 2026
- 8-K · SEC filingJun 17, 2026
Get alerts when INMB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days